Immunity Pharma Israeli Company
Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Health Tech & Life Sciences
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Office Locations
Jerusalem, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/immunity-pharma
[2]
crunchbase.com
- https://www.crunchbase.com/organization/immunity-pharma-ipl
External links are provided for reference and verification purposes.